This conference call transcript was computer generated and almost certianly contains errors. This transcript is provided for information purposes only.EarningsCall, LLC makes no representation about the accuracy of the aforementioned transcript, and you are cautioned not to place undue reliance on the information provided by the transcript.
12/14/2023
Greetings and welcome to the Streamlined Health Solutions third quarter 2023 earnings conference call. At this time, all participants are in a listen-only mode. A brief question and answer session will follow the formal presentation. If anyone should require operator assistance during the conference, please press star zero on your telephone keypad. As a reminder, this conference is being recorded. It is now my pleasure to introduce your host, Jacob Goldberger. Thank you. Please go ahead.
Thank you for joining us for the Corporate Update and Financial Results Review of Streamlined Health Solutions for the third quarter of 2023, which ended October 31st, 2023. As the conference call operator indicated, my name is Jacob Goldberger. Joining me on the call today are T. Green, Executive Chairman, Ben Stilwell, President and Chief Executive Officer, and B.J. Reeves, Interim Chief Financial Officer. At the conclusion of today's prepared remarks, we will open the call for a question and answer session. If anyone participating on today's call does not have a full text copy of our press release announcing these results, you can retrieve it from the company's website at www.streamlinehealth.net or from numerous financial websites. Before we begin with prepared remarks, we want to be sure we are clear for everyone on the record how certain information which may be provided today as all of our in-ex calls should be viewed. We therefore submit for the record the following statement. Statements made on this conference call that are not historical facts are considered to be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These are subject to risks, uncertainties, assumptions, and other factors that could cause actual results to differ materially from those we may discuss. Please refer to the company's press releases and filings made with the U.S. Securities and Exchange Commission, including our most recent Form 10-K Annual Report, which is on file with the SEC for more information about these risks, uncertainties, and assumptions, and other factors. As always, we are presenting management's current analysis of these items as of today. Participants on this call should take into account these risks when evaluating the topics we will discuss. Please note, Streamline is not undertaking any commitment or obligation to publicly revise any such forwarding statements made today. On today's call, we will discuss non-GAAP financial measures such as adjusted EBITDA and booked SAS ACV. Management uses these measures to help provide better insight into our financial performance. However, certain items of income and expense are not included in these measures, so these calculations may differ from those which another entity may utilize in calculating their own non-GAAP measures. To help me compare these amounts on consistent terms, please refer to our website at www.streamlinehealth.net and our earnings release for a reconciliation of such non-GAAP measures to the most comparable GAAP measures. I would now like to turn the call over to T. Green, Executive Chairman.
Thank you, Jacob, and thank you all for joining us this morning. As previously announced, on October 13, 2023, the company executed a strategic restructuring. Ben Stilwell was promoted to the role of CEO, supported by BJ Reeves as our interim CFO, while I've stepped into the role of executive chairman. Since the execution of the restructuring, the strategic decisions made by Ben and BJ have confirmed the board's confidence in this leadership team. Dreamline remains committed to its mission to ensure our health system clients are compensated for the care they provide. This has never been more critical for our nation's health systems. And we know that preserving in our effort to deliver pre-bill revenue cycle solutions will deliver tremendous value for clients, shareholders, and our associates. The board and management understand the long-term value of this business and are evaluating several options to improve the company's financial flexibility. We expect to update you in the near future on our progress. With that, I'd like to turn the call over to Ben for our corporate update.
You're reading a preview of the STRM Q3 2023 earnings call.
Free account.
